Since 1996 the Meningococcal Reference Unit (MRU) in Manchester has provided a national service for PCR confirmation of meningococcal and pneumococcal disease. Neisseria meningitidis serogroup B is predominant in the UK, accounting for .60 % of cases. In response to this, the MRU has developed a quadruplex quantitative PCR that detects N. meningitidis capsule transporter (ctrA), serogroup B sialyltransferase (siaD B ), Streptococcus pneumoniae pneumolysin (ply) and an internal control. The assay was prepared in a ready-touse lyophilized format by Applied Biosystems. Laboratory validation showed excellent performance in a specificity panel of 52 isolates and improved detection in comparison with the routine assay. Testing of 244 patient samples showed sensitivity of 93 % [95 % confidence interval (CI): 88-98 %] for the ctrA assay, 95 % (95 % CI: 91-100 %) for the siaD B assay and 100 % (95 % CI: 95-100 %) for the ply assay. Specificity was 100 % (95 % CI: 98-100 %) for both meningococcal targets and 95 % (95 % CI: 92-98 %) for ply. The quadruplex also retained high performance in mixed samples and had acceptable reproducibility. After introduction of the quadruplex into routine use the turnaround time for N. meningitidis group B PCR confirmation reduced from 37 to 29 h and the internal control has proved useful for detecting inhibitory samples. The quadruplex assay provides rapid group B confirmation of meningococcal positive samples, enabling timely public health interventions for the most common disease-causing meningococcal serogroup in the UK.
INTRODUCTION
Bacterial meningitis is a medical emergency; without prompt antibacterial therapy outcomes include mental defects, loss of limbs and death (Brouwer et al., 2012; Kumar et al., 2006; Proulx et al., 2005; van de Beek et al., 2006) . In the UK, Neisseria meningitidis and Streptococcus pneumoniae are leading causes of community-acquired meningitis and other invasive infections (Campbell et al., 2009; Ladhani et al., 2012; Okike et al., 2014; Parsons et al., 2007) . For w15 years, the Public Health England Meningococcal Reference Unit (MRU) in Manchester has offered a duplex quantitative PCR (qPCR) assay to detect N. meningitidis and S. pneumoniae in clinical samples with further testing to determine serogroup as appropriate.
Due to the success of the N. meningitidis serogroup C vaccine, serogroup B is now the leading cause of meningococcal infection in the UK (Campbell et al., 2009; Ladhani et al., 2012; Public Health England, 2015a) . In response to this, the MRU has developed a quadruplex qPCR assay with an aim of reducing turnaround time by simultaneous specific meningococcal DNA detection with group B confirmation. The quadruplex contains primers against N. meningitidis capsule transporter (ctrA), serogroup B sialyltransferase (siaD B ), S. pneumoniae pneumolysin (ply) and an internal control (Cucurbita cv. Kurokawa amakuri hydroxypyruvate reductase, HPR).
The assay was prepared by Applied Biosystems in a lyophilized format to allow long-term storage and eliminate operator error in master mix preparation. Assay validation followed Public Health England guidelines (Saunders et al., 2013) . Here, we report the results of validation with laboratory isolates and clinical samples as well as assay performance for the first 6 months after introduction to routine diagnostic use.
METHODS
Bacterial strains. N. meningitidis serogroup B from the National Institute for Biological Standards and Control (reference number 09/ 320) and S. pneumoniae serotype 14 from the National Collection of Type Cultures (reference number 11902) were used as positive controls. The N. meningitidis control from the National Institute for Biological Standards and Control was a heat-inactivated cell suspension that was used for nucleic acid extraction directly. All other bacteria were grown on Columbia agar with horse blood (Oxoid) or Iso-sensitest agar with horse blood and 20 mg NAD l 21 (Oxoid) for 24 h at 37 uC, two colonies were suspended in 2 ml molecular grade water (Promega), 200 ml of this suspension was heated at 100 uC for 10 min using a QBD4 heating block (Grant Instruments), and this boilate was used for nucleic acid extraction. Neat positive controls corresponded to quantification cycle (C q ) *30. Dilutions were made in pathogen-free human plasma as required.
Clinical samples. To determine the sensitivity and specificity of the quadruplex in clinical samples, records were retrieved from the laboratory information management system for all samples tested with the routine qPCR as well as confirmed meningococcal culture isolates from 5 July 2010 to 28 June 2011. Clinical data and samples were anonymized prior to use in this study. Samples were considered positive for serogroup B meningococci if positive by qPCR (ctrA and siaD B ) and culture from the same presentation. Samples were considered positive for pneumococci if positive by qPCR for the screen (ply) and confirmation (lytA) targets. Samples negative for both pathogens were also gathered. Clinical samples were retrieved from storage at 280 uC in a sequential fashion regardless of previous C q . Sample types tested included EDTA blood, cerebrospinal fluid (CSF), serum, pleural fluid, drain fluid, plasma, nasopharyngeal aspirate and throat swab. This work was reviewed by the local ethics committee.
DNA extraction. All samples were extracted using an automated BioRobot MDx (Qiagen) following the manufacturer's instructions. The internal control oligonucleotide was included in the lysis buffer and was thus added to each sample. Input volume was 300 ml with DNA being eluted into 100 ml elution buffer (10 mM Tris/HCl, 0.5 mM EDTA, pH 9.0). After extraction, DNA was stored at 4 uC for up to 48 h prior to qPCR testing and thereafter at 280 uC.
qPCR. The quadruplex was custom-made in a lyophilized format by Applied Biosystems with primer and probe sequences provided by the MRU; the components of the master mix have not been disclosed by the company as this is a commercial service. Lyophilized reagents were rehydrated with 20 ml molecular-grade water (Promega) and then 5 ml sample extract was added. Amplification and detection was done on a TaqMan 7500 (Applied Biosystems) using fast cycling conditions (2 min at 95 uC, then 45 cycles of 95 uC for 3 s and 60 uC for 30 s). Primers and hydrolysis probes for both qPCR assays are described in Table 1 ; an additional ctrA reverse primer (RP2) has been included since 2003 to address a small number of clinical cases not detected by the original set (Guiver et al., 2011; Gray et al., 2012) . Samples were tested in triplicate by qPCR and considered positive if two or more replicates produced detectable signals. Samples were considered negative if two or three replicates were unreactive (C q 545) with the internal control detected at C q 520+3. Positive controls for both N. meningitidis serogroup B and S. pneumoniae (see Bacterial strains) as well as no template controls were included in every qPCR run. The quadruplex was compared to the routine diagnostic system: a duplex qPCR for ctrA and ply with a further qPCR for siaD B (Corless et al., 2001) .
Analytical specificity. A panel of control strains was used to determine analytical specificity ( Table 2 ). The presence of bacterial DNA was confirmed by 16S rDNA qPCR prior to testing on the quadruplex (Corless et al., 2000) . The viral, fungal and parasite strains were in-use controls from the molecular diagnostics laboratory, and were proven to have detectable nucleic acid in the relevant assay prior to testing with the quadruplex.
Analytical sensitivity comparison. N. meningitidis and S. pneumoniae were tested in parallel on both systems to allow comparison of end-points. High positive samples (C q *22) were serial diluted to 10 25 and run in triplicate on both qPCR assays. A paired t-test was used to compare mean C q at each dilution on the two assays. In all analyses, two-tailed Pj0.05 was regarded as statistically significant. Concordance between the two assays was calculated using Lin's concordance correlation coefficient (McBride, 2005) .
Evaluation of internal control reaction. Inhibition of the quadruplex assay was performed by adding heparin (Sigma-Aldrich) to the 21 . This dilution series was used to rehydrate separate assay beads in triplicate (20 ml per bead) giving final concentrations of 1.86, 0.93, 0.46, 0.23, 0.12 and 0.06 IU per reaction. Un-spiked reactions were included as controls. N. meningitidis and S. pneumoniae DNA extracts (5 ml) were added to the reaction mixes in triplicate and the qPCR protocol was run. C q at each heparin concentration for each target was then compared with heparin-free controls by the t-test (Pj0.05).
Reproducibility. Reproducibility was determined by testing serial dilutions of bacterial DNA in triplicate on three separate runs. Target material corresponding to C q *30 was tested neat, 1/10, 1/50, 1/100, 1/200, 1/400, 1/800 and 1/1600 (ctrA and siaD B ) or neat, 1/10, 1/50, 1/100, 1/200, 1/400, 1/800, 1/1000, 1/2000, 1/4000 and 1/8000 (ply). Mean C q was calculated for each run at each dilution and the percentage variation calculated against the first run. As the dilution series covered medium to low levels of target concentrations, percentage variation v15 % for all dilutions was considered acceptable reproducibility.
RESULTS

Analytical specificity
In total, 52 laboratory control isolates of pathogens commonly encountered in blood or CSF were tested on the quadruplex to determine analytical specificity ( Table 2) . The quadruplex correctly identified all isolates in this panel, with no false-positive or -negative reactions and consistent detection of the internal control.
Analytical sensitivity comparison
The analytical sensitivities of the quadruplex and routine systems were compared by parallel testing of dilution series. Lin's concordance correlation coefficient was 0.75 [one-sided 95 % confidence interval (CI): 0.58-0.85] for ctrA, 0.79 (95 % CI: 0.62-0.88) for siaD B and 0.89 (95 % CI: 0.72-0.94) for ply, indicating that results for all targets were discordant on the two assays. The quadruplex had higher analytical sensitivity for all targets, as indicated by consistently lower C q s over the dilution series (Fig. 1) . The effect of assay competition was also investigated by testing titrations of mixed bacteria. Compared with single-target reactions, both assays had higher C q s in the presence of mixed DNA, suggesting some effect of intertarget competition. Competition had more of an effect In-house control Improved diagnosis of meningococcal/pneumococcal infections on detection by the routine system, where high levels of one species inhibited the detection of the other species in low concentration; in the same samples the quadruplex produced reliable signals for both species (Fig. S1 , available in the online Supplementary Material). Also, two patient samples were identified that were previously diagnosed as mixed N. meningitidis serogroup B and S. pneumoniae by qPCR; when retested these yielded equal or stronger C q s in the quadruplex assay.
Performance with clinical samples
Patient samples with N. meningitidis serogroup B (n587), S. pneumoniae (n561) or neither pathogen detected (n596) were used to determine clinical sensitivity, specificity and predictive values on the quadruplex (Table 3) . Positive samples were considered negative for the remaining target(s) to detect false-positive reactions, giving 157 meningococci-and 183 pneumococci-negative samples in total. Clinical samples included EDTA whole-blood (n5179), CSF (n538), serum (n511), pleural fluid (n56) and other sample types (n510).
A further eight samples previously meningococcal qPCRnegative, culture-positive were tested with the quadruplex. Meningococcal DNA was detected in all samples, to the serogroup level in seven. Five of these were siaD B -positive only, the median C q was 37 (range 36-40), highlighting the ability to detect low-level positives in the quadruplex set-up.
Additionally, seven clinical samples from viral meningitis were tested. Enterovirus (n51), herpes simplex virus-1 (n52), herpes simplex virus-2 (n51) or varicella-zoster virus (n52) did not produce a signal in the quadruplex. One sample from a confirmed enterovirus and S. pneumoniae dual infection was positive for the ply target in the quadruplex. 
Evaluation of internal control reaction
The response of the internal control to inhibition was determined by spiking the qPCR mix with increasing concentrations of heparin (Satsangi et al., 1994; Yokota et al., 1999) . Inhibition was defined as a significant difference (Pj0.05) in C q between a specific heparin spiked reaction and unspiked control. All targets were inhibited from 0.12 IU heparin per reaction; the degree of inhibition increased in a dose-dependent manner, with all reactions being fully inhibited at 0.93 IU heparin per reaction (Fig.  2) . These results demonstrated that a deviation from the expected internal control C q indicated inhibition of the entire reaction and results should be interpreted appropriately.
Reproducibility
Reproducibility was determined by testing at least eight dilutions of target material in triplicate on three separate days, giving nine replicates at each dilution. At high target concentrations, the quadruplex had good reproducibility, but at lower concentrations this dropped due to Poisson distribution of target (Table 4) . As the dilution series covered moderate-to-low target concentrations, we defined acceptable reproducibility as v15 % variation; all samples were below this threshold (Table 4) . In diagnostic use, any samples giving unexpected or discordant results would be repeated for confirmation, where possible.
Monthly stability checks of lyophilized beads stored at 4 uC and room temperature did not detect loss of reaction efficiency over 1 year, although beads stored at room temperature did become difficult to suspend after 2 months.
Routine use of quadruplex
After validation, the quadruplex was passed as suitable for diagnostic use and was introduced into the routine laboratory in November 2011, replacing the incumbent assay. In the first 6 months of routine use (November 2011-May 2012), a total of 5510 clinical samples from 4807 patients were tested with the quadruplex assay: 3281 (77.7 %) bloods (mainly EDTA), 1115 (20.2 %) CSFs, 79 (1.4 %) fluids and 35 (0.6 %) were other sample types.
A total of 339 ctrA-positive samples (277 patients) were detected, of which 289 (237 patients, 85.5 %) were confirmed as group B. Prior to introduction of the quadruplex, turnaround time for confirmed serogroup B samples was 37 h; this dropped to 29 h after introduction of the quadruplex. Twelve inhibitory samples were detected, four of which were blood culture bottle fluids. Also, no clinical Improved diagnosis of meningococcal/pneumococcal infections samples were ctrA-negative but siaD B -positive, and there was no discordance between positive culture of meningococci and ctrA negativity. There is currently no evidence of ctrA or siaD B primer sequence variants in the patient population.
DISCUSSION
We describe the validation and routine use of a lyophilized quadruplex qPCR assay to detect the most common causes of community-acquired bacterial meningitis in the UK. The assay also includes an internal control to detect inhibitory samples and laboratory process errors. The quadruplex showed high sensitivity, specificity and reproducibility when tested with laboratory strains and clinical samples.
Nucleic-acid-based detection of N. meningitidis and S. pneumoniae has previously been shown to have high sensitivity and specificity (Bøving et al., 2009; Corless et al., 2001; Parent du Châtelet et al., 2005; Sacchi et al., 2011; Tzanakaki et al., 2005) . The ctrA target is N. meningitidis species-specific so ensures that the quadruplex will detect multiple N. meningitidis serogroups; this is important in the UK where serogroups W135 and Y have increased in recent years (Public Health England, 2015b) , as well as in other countries where serogroup B is not the main cause of meningococcal infections. We have validated the detection of N. meningitidis serogroups 29E, A, B, C, D, W135, Y and Z. The inclusion of the ctrA and siaD B assays in the quadruplex allows reduced diagnostic turnaround time of serogroup B, which causes 66.7 % of invasive meningococcal infections in England and Wales (Public Health England, 2015a) . Reduced turnaround time will potentially lead to earlier public health responses and better antimicrobial stewardship (Wang et al., 2012) . The use of two meningococcal targets also increases the chance of detecting samples with low levels of bacterial DNA; five culture-positive ctrA/ ply duplex qPCR-negative samples were low-level positive by siaD B only with the quadruplex. The inclusion of an additional reverse primer for N. meningitidis ctrA (RP2) allows the detection of sequence variants identified by Cavrini et al. (2010) and Jaton et al. (2010) . We have used RP2 since 2003; on-going surveillance has not detected any further sequence variants in clinical samples (Guiver et al., 2011; Gray et al., 2012) .
Two N. meningitidis clinical samples were positive by siaD B only, whilst four were negative for both meningococcal targets. These false-negative samples were not inhibitory based on the internal control result, and as the primer sets were the same in the quadruplex and comparator, it is unlikely that amplification failed in the presence of target material. Five of the six samples had high C q s on initial testing prior to storage (ctrA median 40, range 37-42), suggesting sample degradation may have occurred. The remaining false-negative initially had a ctrA C q 527; due to this, the extract was retested on the comparator assay and found to be negative. This suggests a laboratory error during sample selection or that extraction may have occurred, as opposed to failure of the quadruplex.
The quadruplex was 100 % sensitive and 95.1 % specific for S. pneumoniae detection when compared with the incumbent routine qPCR (Table 3) . As pneumococcal culture results were unavailable, clinical samples were considered negative for S. pneumoniae if previously negative by ply qPCR. S. pneumoniae respiratory colonization is relatively common in children and has been associated with serum ply positivity (Dagan et al., 1998) . In adults, S. pneumoniae carriage is rarer, but false-positive ply results have still been reported -one suggested reason is the entry of a-haemolytic streptococci from the oral cavity into the bloodstream (Abdeldaim et al., 2010) . However, validation results suggest the quadruplex has higher analytical sensitivity for all targets (Fig. 1) , so it is possible that the false-positive pneumococcal samples contained target DNA below the limit of detection of the routine assay (0) which was detectable by the quadruplex. The nine samples false-positive for ply had high C q s, with only one v37 (median 39, range 32-43) and all were blood samples; without culture results it is impossible to say if these samples contained low levels of a-haemolytic streptococci or S. pneumoniae. The false-positive samples were not tested with the lytA assay, although in routine practice we continue to use lytA to confirm all ply-positive samples due to the reduced specificity of the ply target alone (Carvalho et al., 2007; Sheppard et al., 2004) .
Our results also show that inhibitory samples are reliably indicated by an internal control C q outside the expected range. The internal control oligonucleotide was added during extraction, and so acted as a whole-process control covering extraction, storage and qPCR (Saunders et al., 2013) . The use of lyophilized reagents improves the quality and consistency of the assay by reducing operator error and variation in master mix preparation, and improves the shelf life and stability of the reagents (Al-Talib et al., 2014; Aziah et al., 2007; Klatser et al., 1998) . When multiplexing qPCR targets there is always a danger that one of the reactions will block out signals from the other components of the multiplex; to reduce this we used limiting probes for the internal control.
There are some limitations to this work.
(1) Clinical validation was done retrospectively with samples stored at 280 uC. It is possible that the level of target nucleic acids reduced during storage or upon thawing. To limit the effect of storage, we tested samples in triplicate to increase the chance of detecting low levels of target. (2) We did not have access to culture results from S. pneumoniae-positive patients; culture-based methods are considered the 'gold standard' for identification of S. pneumoniae. To ensure samples were truly positive for S. pneumoniae we only included those positive with ply and lytA qPCRs. (3) The limits of detection for each target have not been determined. However, when tested in parallel with the routine system the quadruplex had stronger signals (Figs 1 and  S1 ). Also, the quadruplex generated signals from eight previously culture-positive but qPCR-negative N. meningitidis serogroup B clinical samples; these results suggest lower limits of detection with the quadruplex.
In conclusion, a novel lyophilized quadruplex qPCR was successfully validated and introduced into the MRU routine diagnostic workflow. Strengths of the new assay include a full-process internal control that confirms the validity of negative results, excellent sensitivity/specificity, increased reproducibility and shelf life due to lyophilization, and the ability to rapidly detect group B meningococcal infections. This assay is an important asset for monitoring the success of the serogroup B vaccine after introduction to the UK infant schedule (Hakin & Cosford, 2015) . Surveillance must continue to monitor the prevalence of specific serogroups within the UK and further afield to inform diagnostic and immunization strategies in the future.
